Nationally Ranked Shareholder Rights Firm Labaton Sucharow Announces Proprietary Investigation of Akcea Therapeutics, Inc. (AKCA)
AKCEA THERAPEUTICS (AKCA)
Last akcea therapeutics earnings: 2/25 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.akceatx.com/media-investors/press-releases
Company Research
Source: Business Wire
NEW YORK--(BUSINESS WIRE)--Labaton Sucharow LLP, a leading and award winning investor rights law firm, announces it is investigating potential breach of fiduciary duty claims on behalf of shareholders of Akcea Therapeutics, Inc. (NASDAQ: AKCA).Akcea is a development and commercialization company focused on helping patients with serious diseases. Akcea purports to drive clinical program execution, understand patient and physician needs, prepare the market, create market access, and commercialize products on a global basis.Our investigation arises from an analysis of pharmaceutical company Ionis, a majority, controlling stockholder of Akcea. In 2010, Ionis entered into a collaboration agreement with Glaxo Group Limited (“GSK”), pursuant to which Ionis would develop inotersen, an antisense drug for the treatment of ATTR amyloidosis (“ATTR”), and GSK would shoulder the research costs and share in the profits after inotersen’s commercialization.In 2017, amid inotersen safety concerns a
Show less
Read more
Impact Snapshot
Event Time:
AKCA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AKCA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AKCA alerts
High impacting AKCEA THERAPEUTICS news events
Weekly update
A roundup of the hottest topics